THE DEVELOPMENT OF TAMOXIFEN FOR BREAST-CANCER THERAPY - A TRIBUTE TO THE LATE WALPOLE,ARTHUR L

被引：119

作者：

JORDAN, VC ^{[1
]}

机构：

[1] UNIV WISCONSIN, DEPT PHARMACOL, MADISON, WI 53792 USA

来源：

BREAST CANCER RESEARCH AND TREATMENT | 1988年 / 11卷 / 03期

关键词：

D O I：

10.1007/BF01807278

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：197 / 209

页数：13

共 144 条

[1] METABOLISM OF TAMOXIFEN IN HUMANS [J].

ADAM, HK ;

DOUGLAS, EJ ;

KEMP, JV .

BIOCHEMICAL PHARMACOLOGY, 1979, 28 (01) :145-147

[2] MEASUREMENT OF TAMOXIFEN IN SERUM BY THIN-LAYER DENSITOMETRY [J].

ADAM, HK ;

GAY, MA ;

MOORE, RH .

JOURNAL OF ENDOCRINOLOGY, 1980, 84 (01) :35-42

[3] ZOLADEX - A SUSTAINED-RELEASE, MONTHLY LUTEINIZING-HORMONE-RELEASING HORMONE ANALOG FOR THE TREATMENT OF ADVANCED PROSTATE-CANCER [J].

AHMANN, FR ;

CITRIN, DL ;

DEHAAN, HA ;

GUINAN, P ;

JORDAN, VC ;

KREIS, W ;

SCOTT, M ;

TRUMP, DL .

JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (06) :912-917

[4]

AHMED SR, 1983, LANCET, V2, P415

[5] EVIDENCE FOR THE METABOLIC-ACTIVATION OF NON-STEROIDAL ANTIOESTROGENS - A STUDY OF STRUCTURE-ACTIVITY-RELATIONSHIPS [J].

ALLEN, KE ;

CLARK, ER ;

JORDAN, VC .

BRITISH JOURNAL OF PHARMACOLOGY, 1980, 71 (01) :83-91

[6]

BAUM M, 1983, LANCET, V1, P257

[7]

BAUM M, 1985, LANCET, V1, P836

[8]

Beatson AT, 1896, LANCET, V2, P104

[9] COMBINATION CHEMOTHERAPY AS AN ADJUVANT TREATMENT IN OPERABLE BREAST-CANCER [J].

BONADONNA, G ;

BRUSAMOLINO, E ;

VALAGUSSA, P ;

ROSSI, A ;

BRUGNATELLI, L ;

BRAMBILLA, C ;

DELENA, M ;

TANCINI, G ;

BAJETTA, E ;

MUSUMECI, R ;

VERONESI, U .

NEW ENGLAND JOURNAL OF MEDICINE, 1976, 294 (08) :405-410

[10]

BORGNA JL, 1981, J BIOL CHEM, V256, P859

← 1 2 3 4 5 6 7 8 9 10 →